<DOC>
	<DOCNO>NCT00188474</DOCNO>
	<brief_summary>There much data literature regard optimal treatment approach malignant pleural effusion assess patient outcome . However , data quality life satisfaction treatment patient 's perspective available .</brief_summary>
	<brief_title>A Quality Life Study Management Malignant Pleural Effusions</brief_title>
	<detailed_description>This study compare various treatment strategy management malignant pleural effusion respect : 1 . Primary endpoint : successful palliation symptomatic pleural effusion assess London Chest Activity Daily Living Scale ( LCADLS ) 2 . Secondary endpoint : ) impact treatment patient quality life assess Functional Assessment Chronic Illness Therapy - Palliative patient ( FACIT-PAL ) questionnaire ii ) Assessment patient satisfaction treatment receive via Functional Assessment Chronic Illness Therapy-Treatment Satisfaction ( FACIT-TS ) questionnaire iii ) Pleurodesis success rate assess 2 6-week effusion control rate CXR iv ) Requirement hospitalization procedures treatment recurrent effusion v ) Comparison morbidity mortality rate differ treatment approach vi ) comparison cost Canadian health care set differ treatment approach</detailed_description>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<criteria>symptomatic pleural effusion history malignant disease age great 18 year consent participate study significant ipsilateral endobronchial disease prior ipsilateral , intrapleural therapy , define : prior chest tube placement effusion , prior attempt chemical/surgical pleurodesis , prior surgical pleurectomy active pulmonary pleural infection granulocyte &lt; 1500/mm3 , platelet &lt; 50,000/mm3 systemic chemotherapy within 2 week allergy talc</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>